A carregar...
Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens
INTRODUCTION: Malignant gliomas (MGs) represent the most common primary brain tumors in adults, the most deadly of which is grade IV glioblastoma. Patients with glioblastoma undergoing current standard-of-care therapy have a median survival of 12 – 15 months. AREAS COVERED: Over the past 25 years, t...
Na minha lista:
| Publicado no: | Expert Opin Pharmacother |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4522945/ https://ncbi.nlm.nih.gov/pubmed/25139628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2014.947266 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|